Loading organizations...
Loading organizations...
Biopharmaceutical company developing immunotherapy for food allergies.
DBV Technologies has raised $25.6M across 1 funding round.
DBV Technologies has raised $25.6M in total across 1 funding round.
DBV Technologies has raised $25.6M in total across 1 funding round.
DBV Technologies's investors include InnoBio fund, Lundbeckfond Ventures, ALK Abello, Alto Invest, Apax Partners, Cap D \u00e9cisif, Creagro, Shire, Sofinnova Partners.
DBV Technologies has raised $25.6M across 1 funding round. Most recently, it raised $25.6M Series C in January 2011.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 5, 2011 | $25.6M Series C | InnoBio fund, Lundbeckfond Ventures | ALK Abello, Alto Invest, Apax Partners, Cap D \u00e9cisif, Creagro, Shire, Sofinnova Partners |